Literature DB >> 8375119

A pharmacokinetic perspective on medicament noncompliance.

G Levy1.   

Abstract

Mesh:

Year:  1993        PMID: 8375119     DOI: 10.1038/clpt.1993.143

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  20 in total

1.  Use of sensitivity functions to characterise and compare the forgiveness of drugs.

Authors:  Patrice Nony; Jean-Pierre Boissel
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Bayesian population modeling of drug dosing adherence.

Authors:  Kelly Fellows; Colin J Stoneking; Murali Ramanathan
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-29       Impact factor: 2.745

3.  [Drug therapy in the aged].

Authors:  W von Renteln-Kruse
Journal:  Z Gerontol Geriatr       Date:  2005-06       Impact factor: 1.281

4.  'Hedged' prescribing for partially compliant patients.

Authors:  John Urquhart; Bernard Vrijens
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 5.  The implications of noncompliance with antihypertensive medication.

Authors:  B Girvin; G D Johnston
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

6.  Do we need full compliance data for population pharmacokinetic analysis?

Authors:  P Girard; L B Sheiner; H Kastrissios; T F Blaschke
Journal:  J Pharmacokinet Biopharm       Date:  1996-06

Review 7.  Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor compliance.

Authors:  Jean-Pierre Boissel; Patrice Nony
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 8.  Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens.

Authors:  J Urquhart
Journal:  Pharmacoeconomics       Date:  1999-03       Impact factor: 4.981

9.  Assessment of Markov-dependent stochastic models for drug administration compliance.

Authors:  Diane Wong; Reshma Modi; Murali Ramanathan
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6--an evaluation with the nonparametric maximum likelihood method.

Authors:  M Jerling; Y Merlé; F Mentré; A Mallet
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.